What is myelomonocytic leukemia, the disease suffered by Berlusconi

What is myelomonocytic leukemia, the disease suffered by Berlusconi

The former Italian Prime Minister died at the age of 86 as a result of this diagnosis. How is it and who does it affect?

REUTERS

Italian politician Silvio Berlusconi passed away this Monday morning at the age of 86, due to complications with a chronic myelomonocytic leukemia that affected him years ago. According to what they reported, he had been admitted on Friday to undergo a series of controls at the San Raffaele hospital in Milan, Italy.

Three weeks ago, the former prime minister he had been discharged from a 44-day hospitalization due to a lung infection caused by the same condition. His medical team specified that he had undergone a “specialized cytoreductive treatment” and had undergone chemotherapy.

image.png

REUTERS

What is myelomonocytic leukemia

Chronic myelomonocytic leukemia (CMML) is a type of blood cancer It begins in the blood-forming cells of the bone marrow and is characterized by the presence of abnormally high numbers of monocytes in the blood and bone marrow.

It mainly affects older adultssince it usually be diagnosed after the age of 60. The American Cancer Society indicates that about 15% to 30% of people with this condition may develop an acute facet of disease.

One of the great advances in the last 5 years is that the understanding of the molecular abnormalities that cause disease and “this new knowledge is expected to allow the development of new and better therapeutic treatments,” indicated the Leukemia & Lymphoma Society (LLS), a United States nonprofit organization dedicated to funding blood cancer research and providing education and services to patients.”

Between the symptoms Common forms of chronic myelomonocytic leukemia include:

  • Weakness
  • Fatigue
  • Unexplained bruises
  • bleeding
  • Enlarged liver and spleen

Most patients with chronic myelomonocytic leukemia are treated with medicines and chemotherapy. In recent years, the allogeneic stem cell transplantation as a possible option for some patients.

Source: Ambito

Leave a Reply

Your email address will not be published. Required fields are marked *

Latest Posts